These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11526486)

  • 1. Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis.
    Kanzler S; Meyer E; Lohse AW; Schirmacher P; Henninger J; Galle PR; Blessing M
    Oncogene; 2001 Aug; 20(36):5015-24. PubMed ID: 11526486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.
    Im YH; Kim HT; Kim IY; Factor VM; Hahm KB; Anzano M; Jang JJ; Flanders K; Haines DC; Thorgeirsson SS; Sizeland A; Kim SJ
    Cancer Res; 2001 Sep; 61(18):6665-8. PubMed ID: 11559531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
    Park DY; Hwang SY; Suh KS
    Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
    Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
    Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
    Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
    Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
    Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
    Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
    Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
    Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
    EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
    Sanders S; Thorgeirsson SS
    Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
    Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
    Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
    Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic silicosis, cirrhosis, and liver tumors in mice and hamsters: studies of transforming growth factor beta expression.
    Williams AO; Knapton AD
    Hepatology; 1996 May; 23(5):1268-75. PubMed ID: 8621163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
    Nishikawa Y; Wang M; Carr BI
    J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.